IHC analyses showed the presence of active YAP1 in tumor cells and stromal fibroblasts and demonstrated FAPα immunoreactivity exclusively in stromal fibroblasts (Fig. 1K and Supplementary Fig. S4). This evidence concerns the gene FAP and neoplasm.